"Cannabis Oil" is an evaporated solution of tetrahydrocannabinol and various other compounds produced by a solvent extraction of cannabis....
En.wikipedia.org/wiki/Cannabis_oilWhat Is Simpson-Cannabis Oil
The
Science of Cannabis, The published studies the published reports. The
introduction of Simpson-Cannabis Oil, what it is and how it works and
how and where to get it! Discussions on health during treatments as well
as personal success stories pertaining to the use of Simpson-Cannabis
Oil as a remedy and in some cases a cure, as well as possible side
effects associated with the product. can be objectively assessed
from this site.
Wikipedia
Simpson
- Cannabis Oil is an evaporated solution of tetrahydrocannabinol and
various other compounds produced by a solvent extraction of cannabis....
en.wikipedia.org/wiki/Cannabis_oil
How Does It Work
“Cannabinoids”
is a blanket term covering a family of complex chemicals (both natural
and man-made) that lock on to cannabinoid receptors – protein molecules
on the surface of cells.
Humans
have been using cannabis plants for medicinal and recreational purposes
for thousands of years, but cannabinoids themselves were first purified
from cannabis plants in the 1940s. The structure of the main active
ingredient of cannabis plants – delta-9 tetrahydrocannabinol (THC) – was
discovered in the 60s. It wasn’t until the late 1980s that researchers
found the first cannabinoid receptor, followed shortly by the discovery
that we create cannabinoid-like chemicals within our own bodies, known
as endocannabinoids.
The CB1 and CB2 receptors.
We
have two different types of cannabinoid receptor, CB1 and CB2, which
are found in different locations and do different things. CB1 is mostly
found on cells in the nervous system, including certain areas of the
brain and the ends of nerves throughout the body, while CB2 receptors
are mostly found in cells from the immune system. Because of their
location in the brain, it’s thought that CB1 receptors are responsible
for the infamous ‘high’ (known as psychoactive effects) resulting from
using cannabis.
Over
the past couple of decades scientists have found that endocannabinoids
and cannabinoid receptors are involved in a vast array of functions in
our bodies, including helping to control brain and nerve activity
(including memory and pain), energy metabolism, heart function, the
immune system and even reproduction. Because of this molecular
multitasking, they’re implicated in a huge range of illnesses, from
cancer to neurodegenerative diseases.
Can Cannabinoids treat cancer & other diseases?
There
is no doubt that cannabinoids – both natural and synthetic – are
interesting biological molecules. Hundreds of scientists around the
world are investigating their potential in cancer and other diseases –
brought together under the blanket organisation The International Cannabinoid Research Society.
Researchers
first looked at the anticancer properties of cannabinoids back in the
1970s, and many hundreds of scientific papers looking at cannabinoids
and cancer have been published since then.
Harvard University scientists reported that
THC slows tumor growth in common lung cancer and “significantly reduces
the ability of the cancer to spread.” What’s more, like a heat-seeking
missile, THC selectively targets and destroys tumor cells while leaving
healthy cells unscathed. Conventional chemotherapy drugs, by contrast,
are highly toxic; they indiscriminately damage the brain and body.
There
is mounting evidence, according to a report in Mini-Reviews in
Medicinal Chemistry, that cannabinoids “represent a new class of
anticancer drugs that retard cancer growth, inhibit angiogenesis [the
formation of new blood cells that feed a tumor] and the metastatic
spreading of cancer cells.”
Dr.
Sean McAllister, a scientist at the Pacific Medical Center in San
Francisco, has been studying cannabinoid compounds for 10 years in a
quest to develop new therapeutic interventions for various cancers.
Backed by grants from the National Institute of Health (and with a
license from the DEA), McAllister discovered that cannabidiol (CBD), a
nonpsychoactive component of the marijuana plant, is a potent inhibitor
of breast cancer cell proliferation, metastasis, and tumor growth.
In
2007, McAllister published a detailed account of how cannabidiol kills
breast cancer cells and destroys malignant tumors by switching off
expression of the ID-1 gene, a protein that appears to play a major role
as a cancer cell conductor.
The
ID-1 gene is active during human embryonic development, after which it
turns off and stays off. But in breast cancer and several other types of
metastatic cancer, the ID-1 gene becomes active again, causing
malignant cells to invade and metastasize. “Dozens of aggressive cancers
express this gene,” explains McAllister. He postulates that CBD, by
virtue of its ability to silence ID-1 expression, could be a
breakthrough anti-cancer medication.
“Cannabidiol
offers hope of a non-toxic therapy that could treat aggressive forms of
cancer without any of the painful side effects of chemotherapy,” says
McAllister, who is seeking support to conduct clinical trials with the
marijuana compound on breast cancer patients.
McAllister’s
lab also is analyzing how CBD works in combination with first-line
chemotherapy agents. His research shows that cannabidiol, a potent
antitumoral compound in its own right, acts synergistically with various
anti-cancer pharmaceuticals, enhancing their impact while cutting the
toxic dosage necessary for maximum effect.
